You have 9 free searches left this month | for more free features.

Y90

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in Manchester (Y90-PET-CT scan)

Recruiting
  • Cancer
  • Y90-PET-CT scan
  • Manchester, United Kingdom
    The Christie NHS - Nuclear Medicine Department
Nov 7, 2023

Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo

Recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • SIRT-Y90 with Atezolizumab + Bevacizumab
  • SIRT-Y90 with Placebo (IV)
  • Singapore, Singapore
  • +1 more
Jan 26, 2023

Liver Cancer Trial in Houston (device, diagnostic test, procedure)

Not yet recruiting
  • Liver Cancer
  • TriSalus™ TriNav™Infusion System
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Feb 23, 2023

Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Y-90 TARE
  • +2 more
  • Washington, District of Columbia
  • +5 more
Jan 18, 2023

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

Recruiting
  • Pancreatic Neuroendocrine Tumor
  • peptide receptor radionuclide therapy with Y-90-DOTATOC
  • Milano, Italy
  • +1 more
Sep 30, 2022

HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)

Active, not recruiting
  • HepatoCellular Carcinoma
  • Singapore, Singapore
    National Cancer Centre - Singapore
May 25, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

HCC, Cancer of Liver, Cancer Trial in Atlanta (SIR-Spheres microspheres)

Completed
  • HCC
  • +2 more
  • SIR-Spheres microspheres
  • Atlanta, Georgia
  • +2 more
Dec 22, 2021

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023

Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres

Recruiting
  • Hepatocellular Carcinoma
  • SIRT with Y-90 resin microspheres
  • Dallas, Texas
    Methodist Dallas Medical Center
Nov 9, 2021

CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

Recruiting
  • CNS Lymphoma
  • Essen, Germany
    University Hospital Essen
Nov 16, 2023

Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Unresectable Hepatocellular Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Optimizing Y90 Therapy for Radiation Lobectomy

Recruiting
  • HCC
  • +4 more
  • Y90 radioembolization
  • Chicago, Illinois
    Northwestern University
Aug 27, 2021

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)

Completed
  • Primary Malignant Liver Neoplasm
  • Computed Tomography (CT)
  • +4 more
  • Palo Alto, California
    Stanford University
Dec 8, 2021

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, sintilimab plus SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab and Bevacizumab
  • Y90 + TKI
  • Chicago, Illinois
    Northwestern University
Nov 11, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022